Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.53	21.62	8.71	16.9	22.64	45.04
Cash & Short-Term Investments	14.53	21.62	8.71	16.9	22.64	45.04
Cash Growth	579.06%	148.09%	-48.45%	-25.32%	-49.75%	12.67%
Other Receivables	-	-	-	-	2.5	3.66
Total Trade Receivables	-	-	-	-	2.5	3.66
Other Current Assets	1.46	1.46	1.95	2.16	2.32	3.86
Total Current Assets	15.98	23.08	10.66	19.07	27.45	52.57
Net Property, Plant & Equipment	3.92	4.11	4.93	5.78	6.77	3.96
Other Long-Term Assets	-	-	-	-	-	0.07
Total Assets	19.9	27.19	15.59	24.84	34.22	56.6
Accounts Payable	0.89	0.88	1.24	3.98	3.5	3.46
Accrued Expenses	2.98	4.31	4.2	2.1	2.11	2.08
Current Portion of Long-Term Debt	-	-	-	-	2	11.67
Current Portion of Leases	0.89	0.87	0.77	-	-	-
Other Current Liabilities	-	-	-	1.14	1.1	17.55
Total Current Liabilities	4.76	6.05	6.21	7.22	8.71	34.76
Long-Term Debt	-	-	-	-	1.46	3.71
Long-Term Leases	3.53	3.76	4.63	5.4	6.08	1.34
Other Long-Term Liabilities	-	-	-	-	-	15.58
Total Long-Term Liabilities	3.53	3.76	4.63	5.4	7.54	20.63
Total Liabilities	8.29	9.81	10.84	12.62	16.24	55.39
Common Stock	0.11	0.11	0.08	0.06	0.05	0.05
Additional Paid-in Capital	293.41	292.38	252.25	235.61	223.96	215.23
Retained Earnings	-281.91	-275.12	-247.58	-223.45	-206.04	-214.06
Shareholders' Equity	11.61	17.38	4.76	12.22	17.97	1.22
Total Liabilities & Equity	19.9	27.19	15.59	24.84	34.22	56.6
Total Debt	4.42	4.63	5.4	5.4	9.54	16.72
Net Cash (Debt)	10.1	16.99	3.32	11.51	13.1	28.33
Net Cash Growth	-40.54%	412.21%	-71.17%	-12.16%	-53.76%	125.46%
Net Cash Per Share	22.85	53.84	4324.64	1321601.59	1504560.77	3541642.96
Book Value	11.61	17.38	4.76	12.22	17.97	1.22
Book Value Per Share	26.26	55.08	6199.48	1403610.00	2064350.00	152022.00
Tangible Book Value	11.61	17.38	4.76	12.22	17.97	1.22
Tangible Book Value Per Share	26.26	55.08	6199.48	1403610.00	2064350.00	152022.00

SEC Filings: 10-K · 10-Q